Mikrobiomik is a bio-pharmaceutical company founded to conduct research into and develop medicines based on the human microbiome.
Our vision
We aspire to be the first company in the world to market a medicine based on faecal microbiota in the EU. To that end, we are holding talks with both the EMA (European Medicines Agency) and the AEMPS (Spanish Agency for Medicines and Health Products) with a view to establishing protocols on the regulatory requirements for securing an MAA (Marketing Authorization Application) via centralised procedure.
Our values
Mikrobiomik seeks to lead the paradigm shift entailed by designing therapeutic solutions based on the human microbiome through excellence in its processes, empathising with chronic patients for whom no curative treatments are available, always from the perspective of networking with all stakeholders in the sector.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded
Investors
0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
What industry is Mikrobiomik in?
Mikrobiomik operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Mikrobiomik based?
Mikrobiomik is headquartered in Derio, Spain.
Find investors for your startup like Mikrobiomik
Gritt sends AI-personalised outreach to each investor — from your Gmail
